XRAY Form 4: CEO adds RSUs; beneficial ownership 17,698.73
Rhea-AI Filing Summary
DENTSPLY SIRONA (XRAY) reported an insider transaction by President & CEO and Director Daniel T. Scavilla. On 10/10/2025, he acquired 223.681 restricted stock units (RSUs) at $0, recorded as dividend equivalents on existing RSUs. Following this, his beneficial ownership stands at 17,698.73 shares, held directly.
The filing notes these RSU dividends carry the same vesting schedule as the underlying awards, and each RSU converts to one share of common stock upon vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 223.681 shares
Net Buy
1 txn
Insider
Scavilla Daniel T
Role
President, CEO & Member of BOD
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 223.681 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 17,698.73 shares (Direct)
Footnotes (1)
- F1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
FAQ
What did DENTSPLY SIRONA (XRAY) disclose in this Form 4?
The CEO acquired 223.681 RSUs on 10/10/2025 at $0 as dividend equivalents on existing RSUs.
What is the nature of the RSU acquisition reported by XRAY?
They are dividends on RSUs granted as additional RSUs, subject to the same vesting as the original awards.
What is the conversion ratio for the RSUs reported by XRAY?
Each RSU converts 1:1 into one share of DENTSPLY SIRONA common stock upon vesting.
What roles does the reporting person hold at DENTSPLY SIRONA (XRAY)?
He is President, CEO & Member of the Board of Directors.
Was any cash paid for the RSUs acquired in the XRAY filing?
No. The RSUs were acquired at $0 as dividend equivalents.
AI-generated analysis. How Rhea-AI works. Not financial advice.